Withdraw Exkivity
Takeda withdraw Global Lung Cancer Medication, Exkivity, Following Confirmatory Trial Failure
Anika Sharma
Following a disappointing outcome in a confirmatory trial earlier this year, Takeda has decided to discontinue its targeted non-small cell ...
